Quince Therapeutics’ (QNCX) “Buy” Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued their buy rating on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a report issued on Wednesday,Benzinga reports. D. Boral Capital currently has a $12.00 price ...
Le Lézard4d
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPCtm Open-Label Sub-Study in Patients ( 3 Years Old)
Cyclo Therapeutics, Inc. ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and ...
Le Lézard4d
New Market Research on the World Market for Military Infrared Imaging Detectors and Systems (Vol. IRW-M) by Maxtech International, Inc.
Maxtech International, Inc. is releasing the 2025 edition of its market research report on military infrared detectors and systems markets (Vol. IRW-M). Global military infrared imaging systems ...
Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
Five Quince Orchard football seniors announce commitments on National Signing Day
Angel Pelaz, Christopher Koffi, Nathan Brezovec, Trevon Baxter and Triston Pierre reveal their college choices ...
Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...